The recent work of Rier et al. (1) showed that adult female rhesus monkeys exposed daily for 4 years to 5 and 25 ppt of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (3) report that in a group of four of the rhesus monkeys used in Rier et al.'s study, the measured TCDD half-life ranged from 180 days to 788 days. After 4 years of exposure to 25 ppt TCDD in the diet, the whole-weight adipose tissue concentrations were in the range of 245-812 ppt. We assume that one-compartment kinetics apply for TCDD in monkeys and humans. Such an assumption is reasonable because TCDD is essentially stored in fat. Over time, the slow release from the fat compartment becomes the limiting factor of elimination from the body, and TCDD blood concentration at each time is proportional to the fat concentration. Standard results on multiple- 
nificant cause of debilitating pain and infertility in women. We sought to determine whether the levels of total TCDD exposure of the monkeys are within the range of that observed in human populations. As an example, we examined the TCDD levels for a population acutely exposed, via (3) report that in a group of four of the rhesus monkeys used in Rier et al.'s study, the measured TCDD half-life ranged from 180 days to 788 days. After 4 years of exposure to 25 ppt TCDD in the diet, the whole-weight adipose tissue concentrations were in the range of 245-812 ppt. We assume that one-compartment kinetics apply for TCDD in monkeys and humans. Such an assumption is reasonable because TCDD is essentially stored in fat. Over time, the slow release from the fat compartment becomes the limiting factor of elimination from the body, and TCDD blood concentration at each time is proportional to the fat concentration. Standard results on multiple- CArea under curve (AUC) for a 14-year period (4-year exposure to 25 ppt and 10-year follow-up), assuming one-compartment kinetics.
dosing kinetics (4) (6) . For one woman (subject Seveso W), wholeweight adipose tissue concentration was directly measured (6) and does not need to be estimated. Given an estimated halflife for TCDD of 7 years in humans, taken to be independent of sex and age (5,7), it is easy to compute the AUC for wholeweight adipose tissue concentration for [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] (Table 2 ). The blood AUCs are expected to be proportional to those for adipose tissue and in the same proportion for both monkeys and humans. The portion of AUC from first to last contact time at Seveso was neglected because it is small compared to the rest of the area (the exposure period was only 1 or 2 months). These AUCs range from approximately 1,660,000 ppt x day to 112,000,000 ppt/day (on average 24,000,000 ppt x day). The AUCs exceed in all cases the values for monkeys exposed to 25 ppt and should also exceed those for the monkeys exposed to 5 ppt. For any subject, the AUC for 1976-1993 represents 85% of the AUC for 1976-2011, the latter being a measure of the total exposure potentially incurred by the Seveso subjects (assuming that on average they had half a lifetime, i.e., 35 years, left to live at the time of exposure). Therefore, the subjects have already received most of the total integrated exposure expected.
According to this analysis, it is likely that the total exposure to TCDD for some of the 1976 Seveso residents is much greater than that of the monkeys exhibiting endometriosis. Because the monkeys A -3g -~*9 -I dNot available; whole-weight adipose tissue concentration was directly measured for this subject (6).
exposed to 5 ppt in diet also had an increased risk of endometriosis, populations exposed to lower levels than those in Seveso may also be at increased risk if humans are at least as sensitive to the exposure as monkeys. To date, no epidemiologic study has investigated the gynecologic effects of TCDD; given its exposure, the
